ASP Isotopes (ASPI) Expected to Announce Quarterly Earnings on Wednesday

ASP Isotopes (NASDAQ:ASPI) is expected to be issuing its Q4 2025 results before the market opens on Wednesday, March 11th. Analysts expect ASP Isotopes to post earnings of ($0.1367) per share and revenue of $2.0330 million for the quarter. Parties can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Tuesday, March 31, 2026 at 4:00 PM ET.

ASP Isotopes Stock Up 4.5%

ASPI stock opened at $5.80 on Tuesday. The company has a current ratio of 6.14, a quick ratio of 6.10 and a debt-to-equity ratio of 1.04. The firm has a 50-day moving average of $6.22 and a two-hundred day moving average of $7.65. ASP Isotopes has a 12 month low of $3.71 and a 12 month high of $14.49. The company has a market cap of $642.87 million, a price-to-earnings ratio of -4.46 and a beta of 3.55.

Insider Activity

In other news, CFO Heather Kiessling sold 80,000 shares of the business’s stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $5.80, for a total value of $464,000.00. Following the sale, the chief financial officer directly owned 732,500 shares of the company’s stock, valued at approximately $4,248,500. The trade was a 9.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Robert Ainscow sold 8,438 shares of the company’s stock in a transaction that occurred on Friday, March 6th. The stock was sold at an average price of $5.44, for a total transaction of $45,902.72. Following the completion of the transaction, the chief operating officer owned 1,537,817 shares in the company, valued at approximately $8,365,724.48. This represents a 0.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 14.40% of the stock is currently owned by insiders.

Institutional Trading of ASP Isotopes

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ASPI. Integrated Wealth Concepts LLC acquired a new position in shares of ASP Isotopes in the fourth quarter valued at approximately $99,000. Tocqueville Asset Management L.P. acquired a new position in shares of ASP Isotopes in the fourth quarter worth $91,000. J.W. Cole Advisors Inc. acquired a new position in shares of ASP Isotopes in the fourth quarter worth $85,000. Legal & General Group Plc increased its position in shares of ASP Isotopes by 30.4% during the third quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock worth $81,000 after acquiring an additional 1,953 shares during the period. Finally, B. Riley Wealth Advisors Inc. acquired a new stake in shares of ASP Isotopes in the second quarter valued at $121,000. Hedge funds and other institutional investors own 16.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Cantor Fitzgerald initiated coverage on ASP Isotopes in a research note on Thursday, December 4th. They set an “overweight” rating and a $13.00 price objective on the stock. Canaccord Genuity Group reissued a “buy” rating and set a $11.00 price target on shares of ASP Isotopes in a research report on Monday, November 24th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $13.00.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.